Table 3

Comparison of Treatment Characteristics of Patients With Ischemic and Nonischemic Cardiomyopathy

Ischemic Cardiomyopathy
(n = 92,361)
Nonischemic Cardiomyopathy
(n = 63,652)
p Value
Achievement measures
 Discharged with appropriate instruction65,065 (90.5)45,115 (89.8)<0.0001
 LV function documented82,102 (97.5)56,896 (97.2)0.0001
 Patients with LVSD discharged on ACEI/ARB28,863 (90.7)18,862 (93.0)<0.0001
 Patients with LVSD discharged on beta-blockers36,532 (94.9)20,922 (93.9)<0.0001
 Smokers discharged with smoking cessation counseling13,156 (95.8)10,535 (96.3)0.075
Composite performance measures
 100% defect-free care72,586 (85.4)50,438 (85.3)0.63
 Quality measures
 Patients with atrial fibrillation discharged on anticoagulation18,494 (67.6)12,477 (71.5)<0.0001
 Patients with LVSD discharged on aldosterone antagonist11,440 (31.4)7,458 (34.5)<0.0001
 Black patients with LVSD discharged on hydralazine/nitrate1,911 (27.9)1,849 (22.1)<0.0001
 DVT prophylaxis16,567 (68.5)10,889 (70.8)<0.0001
 Influenza vaccine during flu season18,252 (45.4)10,789 (39.0)<0.0001
 Pneumococcal vaccination35,741 (45.5)20,320 (37.9)<0.0001
Procedures
 Cardiac resynchronization therapy-defibrillator2,721 (3.1)1,270 (2.1)<0.0001
 Implantable cardioverter defibrillator only2,955 (3.4)1,494 (2,5)<0.0001

Values are n (%).

ACEI = angiotensin-converting enzyme inhibitor; ARB = angiotensin receptor blocker; DVT = deep vein thrombosis; LV = left ventricle; LVSD = left ventricular systolic dysfunction; NICM = nonischemic cardiomyopathy.

  • Includes all patients with NICM irrespective of whether further etiology was classified.